Biography and education
Professor Alas joined Texas State University in Summer 2025 as Director of Simulation Laboratory and Clinical Assistant Professor at the St. David’s School of Nursing. He brings extensive experience in simulation-based education, clinical instruction, and academic program support across both undergraduate and graduate nursing programs. In his current role, he leads simulation operations, supports curriculum integration, oversees standardized patient programming, facilitates faculty development, and advances the use of evidence-based simulation practices aligned with AACN Essentials and Next Generation NCLEX standards.
Professor Alas earned his Associate of Science in Nursing (ADN) from Glendale Community College, followed by a Bachelor of Science in Nursing (BSN) and a Master of Science in Nursing Education (MSN-Ed) from Chamberlain University. He holds active RN licensure in both Texas and California.
His professional background spans direct patient care, clinical research, nursing education, and leadership in simulation program development. Drawing from his own educational journey, Professor Alas is committed to a student-centered teaching philosophy and to expanding access to high-quality nursing education across diverse learning environments.
Professor Alas earned his Associate of Science in Nursing (ADN) from Glendale Community College, followed by a Bachelor of Science in Nursing (BSN) and a Master of Science in Nursing Education (MSN-Ed) from Chamberlain University. He holds active RN licensure in both Texas and California.
His professional background spans direct patient care, clinical research, nursing education, and leadership in simulation program development. Drawing from his own educational journey, Professor Alas is committed to a student-centered teaching philosophy and to expanding access to high-quality nursing education across diverse learning environments.
Teaching Interests
Research Interests
Featured scholarly/creative works
- Ruane, P., & Alas, B. S. (2010). A 48-week pilot study switching suppressed patients to darunavir/ritonavir and etravirine from enfuvirtide, protease inhibitor(s), and non-nucleoside reverse transcriptase inhibitor(s). AIDS Research and Human Retroviruses, 26(11), 1215–1219. https://doi.org/https://doi.org/10.1089/aid.2009.0285
- Ruane, P., & Alas, B. S. (2008). A Phase IIIb Pilot Study Substituting Darunavir/ritonavir (DRV/r) and Etravirine (ETR) for Enfuvirtide (ENF) and Current PI in a Suppressive Regimen. https://doi.org/https://doi.org/10.1186/1758-2652-11-S1-P68
Featured service activities
- Volunteer
Texas State University Discovery Round Rock
- Volunteer
Workforce Solutions Rural Capital Area
- Member
Interprofessional Education
- Member
CHP Interprofessional Education
- Chair
Simulation IPE Committee
- Member
Director's Council